This is a delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of the pharmaceutical product AIMOVIG 140 MG/ML AUTOINJECTORML. The contract, with a ceiling value of $2,846.52, is a firm fixed price delivery order contract that runs through December 6, 2024.
Dakota Drug, Inc. is the prime contractor for this award and holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical's ECAT Generation V Program, valued at $999,999,999.00, which enables the company to provide a comprehensive range of pharmaceutical products, medical supplies, and healthcare equipment to support U.S. Armed Forces medical operations. This particular delivery order falls under that broader IDC contract vehicle. The contract does not have a set-aside designation.
Generated 3/6/25, 10:11 AM